Clarivate a research organization and global expert in data insights and collection, recognizes the true pioneers in their fields over the last decade, demonstrated by the production of multiple highly-cited papers that rank in the top 1% by citations for each field and year in the Web Of Science™. What Clarivate calls the “one in 1,000” distinction.
This year, and for the second time since it has already been recognized in 2021, Abelardo Margolles co-founder and scientific advisor of Microviable Therapeutics, has been named on the annual Highly Cited Researchers™ 2023 list.
Clarivate noted the societal impact of the winning researchers: “The list identifies and celebrates exceptional individual researchers whose significant and broad influence in their fields translates to impact in their research community and innovations that make the world healthier, more sustainable and more secure. Their contributions resonate far beyond their individual achievements, strengthening the foundation of excellence and innovation in research.”